Genome Canada competition : Disruptive Innovation in Genomics


  • Genome Canada competition : Disruptive Innovation in Genomics

    Code : GC
    Organisator : Génome Canada (GC )
    Year : 2015


    To maximize the benefits for the genomics community, the DIG program will be delivered in two phases:

     

    • Phase 1 will support activities to prove the feasibility of an “idea” – does this technology work and what can it do?
    • Phase 2 will support the development of a prototype (process, product and/or method) advancing the “idea”.

     

    All applicants will need to demonstrate, with supporting evidence, the potential for the innovation to be disruptive, have impact within the technology space, and eventually benefits for Canada. Phase 2 projects must have clear deliverables that will be realized by the end of the project and a plan which explains the next steps of how the deliverables from the research will be transferred, disseminated, used, and/or applied to realize the benefits. The intention is that true disruptive innovation is captured and transferred to those who have the ability to translate and use it, resulting in benefits for Canada.

     

    Genome Canada acknowledges that some potentially disruptive innovations may already have passed the feasibility stage (Phase 1) but require support to develop a prototype to prepare for translation to users (Phase 2). Phase 1 and Phase 2 will, therefore, be run in parallel to support potential disruptive innovations both at the feasibility and development of prototype stages. A second round of Phase 2 funding, open only to eligible Phase 1 projects, will be held 18 months after successful Phase 1 projects are launched. This will allow Phase 1 projects approved for Phase 2 funding to continue to Phase 2 without a gap in funding and for projects not approved for Phase 2 funding to wind down.

     

    Through this Competition, Genome Canada will provide up to $15 million in funding for multiple Phase 1 and Phase 2 projects as follows:

     

     

    Phase 1

    Phase 2

    Genome Canada Funding Available

    Approx. $5 M

    Approx. $10 M

    Co-funding

    Not required

    At least two thirds of project budget

    Genome Canada Investment per Project (Maximum)

    $250,000

    $1 M

    Term of Project (Maximum)

    Two years

    Three years

     

    The application process is comprised of two steps: Registration and Full Application. Applicants are required to apply for funding through their regional Genome Centre. The Request for Application can be found here. For more information, contact your regional Genome Centre.